Robert M. Janosky
Corporate Officer/Principal at SATSUMA PHARMACEUTICALS, INC.
Robert M. Janosky active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SATSUMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2020-03-04 | - |
Career history of Robert M. Janosky
Former positions of Robert M. Janosky
| Companies | Position | Start | End |
|---|---|---|---|
| DURECT CORPORATION | Corporate Officer/Principal | 2015-12-31 | 2020-02-29 |
Training of Robert M. Janosky
| University of Vermont | Undergraduate Degree |
| University of Rochester Simon Business School | Masters Business Admin |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| DURECT CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Satsuma Pharmaceuticals, Inc.
 Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraines. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company was founded by John Kollins on June 21, 2016 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Robert M. Janosky
- Experience
